Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Valeant

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Valeant's Japan sales performance.

valeant

Takeda agrees $5.2bn deal to buy Ariad

Takeda agrees $5.2bn deal to buy Ariad It is the first major acquisition under Takeda chief executive Christophe Weber since he joined the company from GlaxoSmithKline (GSK) in 2014, after earlier negotiations with Valeant over the sale of

Making a list and checking it twice…

Making a list and checking it twice… Let's start with an obvious one: prices and price increases. The hangover effect of Martin Shkreli and Valeant Pharmaceuticals in 2015 continued to haunt the industry along with new dramas

Valeant's proposed sale of Salix to Takeda 'in jeopardy'

Valeant's proposed sale of Salix to Takeda 'in jeopardy' Xifaxan and Relistor are integral to our gastrointestinal franchise which remains a core asset for future growth potential in the hands of Valeant.". ... hoping Valeant's debt burden would encourage it to do a deal at a knockdown price.

Valeant's ex-CEO and CFO 'could face criminal charges'

Valeant's ex-CEO and CFO 'could face criminal charges' The saga continues at Canadian drugmaker Valeant, with reports emerging that former CEO Michael Pearson and CFO Howard Schiller are under criminal investigation for accounting fraud. ... A Bloomberg report quotes unnamed sources as suggesting that the

EpiDemic

EpiDemic And the next egregious drug-pricing headline is yet to come. But like Valeant and Martin Shkreli before it, the EpiPen narrative teaches us some important lessons.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
VISFO

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...